Your session is about to expire
← Back to Search
Behavioural Intervention
Respiratory Music Therapy for Post-Covid-19 Respiratory Symptoms
N/A
Waitlist Available
Led By Joanne V Loewy, DA
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Experiencing residual pulmonary issues (shortness of breath, fatigue)
MRC Dyspnea score of grade 3, 4, or 5
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial is testing a music therapy protocol to see if it can help people with post-Covid-19 respiratory symptoms. The goal is to improve quality of life by reducing fatigue, depression, and improving sleep and resilience.
Eligible Conditions
- Shortness of Breath
- Post-Covid Respiratory Syndrome
- COVID-19
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are still having problems with your breathing and feeling tired.
Select...
You have severe difficulty in breathing, as determined by a special breathing assessment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
MRC dyspnea score
Secondary outcome measures
Beck Depression Inventory - short form (BDI-SF)
Connor-davidson Resilience Scale (CD-RISC)
Coronavirus Anxiety Scale (CAS)
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Individuals living with post-Covid-19 respiratory symptomsExperimental Treatment1 Intervention
Live virtual music therapy interventions for people experiencing difficulties breathing after having had COVID-19 (diagnosed or presumed).
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
852 Previous Clinical Trials
535,899 Total Patients Enrolled
Joanne V Loewy, DAPrincipal InvestigatorDirector Louis Armstrong Center for Music & Medicine,
1 Previous Clinical Trials
82 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are still having problems with your breathing and feeling tired.You have severe difficulty in breathing, as determined by a special breathing assessment.You have mild to moderate difficulty in breathing, as rated by a breathing test.You have respiratory problems, but you do not have a confirmed or likely diagnosis of COVID-19.
Research Study Groups:
This trial has the following groups:- Group 1: Individuals living with post-Covid-19 respiratory symptoms
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available vacancies for participants in this research undertaking?
"Per the clinicaltrials.gov database, this experiment is no longer recruiting volunteers; it was initially posted on January 13th 2022 and last updated in September 16th 2021. Despite its closure, 1098 other trials are currently open for enrollment."
Answered by AI
Share this study with friends
Copy Link
Messenger